Cardiovascular & Lipid Research in Montana & Utah
Cardiology, cardiovascular imaging and metabolic research expertise across Boeson’s Montana and Utah locations.
Investigator expertise and research experience
Dr. Charles Dahl in Provo brings decades of cardiovascular research leadership and career PI experience in acute coronary syndromes, cardiovascular outcomes and lipid-lowering therapies. Dr. Alexander Jehle in Missoula brings cardiology, advanced cardiac CT and MR training, and prior multicenter research experience as a new Boeson investigator. Dr. Aubrey Remmers adds metabolic and cardiovascular-risk study experience in Missoula.
Research experience and interests
- Cardiovascular prevention and outcomes
- Cholesterol and lipid disorders
- Cardiovascular imaging expertise
- Cardiometabolic risk and diabetes
For volunteers
Cardiovascular studies may consider your medical history, laboratory results, medicines and prior cardiovascular events. Ask about the study’s procedures and how records from your treating clinician may be requested with your permission. Continue regular care and follow your clinician’s instructions.
Build your Boeson site shortlist
Bring your cardiovascular program to Dr. Dahl in Provo and the Missoula team of Drs. Jehle and Remmers. Their complementary backgrounds span cardiovascular trial leadership, advanced cardiac imaging and metabolic research. Request an investigator and location comparison for your outcomes, imaging or cardiometabolic protocol.
Meet the investigators
Explore relevant locations
These links describe location expertise, not a promise of an open study.
Does a cardiologist’s imaging expertise mean every scan is available on site?
No. Imaging access, equipment and facility arrangements are confirmed for each proposed study and location.
Choose your next step
Contact the local team to ask about current availability, or share a nonconfidential study synopsis for feasibility.
Research experience does not mean a study is currently enrolling. Participation is voluntary; risks and possible benefits are explained through the study-specific consent process. Content updated September 2026.